CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Open-market sale President and CEO sold 50,000 shares at an average $7.71 ($385,250)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 50,000 shares at an average $8.04 ($402,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 50,000 shares at an average $7.38 ($368,750)
- 4 Open-market buy Vice President and CFO bought 3,268 shares at $6.30 ($20,583)
- 4 Open-market buy Chief Operating & Med. Officer bought 3,267 shares at $6.30 ($20,577)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $8.59 ($429,250)
- 4/A Gift President and CEO gave 16,000 shares (gift)
- 4 Gift President and CEO gave 17,400 shares (gift)
- 4 Open-market sale President and CEO sold 50,000 shares at $8.16 ($408,000)
- 4 Option exercise Chief Operating & Med. Officer acquired 50,000 shares (option exercise)
- 4 Open-market buy 10% owner bought 174,700 shares at an average $9.11 ($1,592,016)
- 4 Open-market sale President and CEO sold 25,000 shares at $8.93 ($223,250)
Page 20 of 30 · 591 filings